Advanced search
Publication Cover
Leukemia & Lymphoma Volume 62, 2021 - Issue 14
Submit an article Journal homepage
733
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant

Jan Philipp Bewersdorfa Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, Yale University, New Haven, CT, USAORCID Iconhttps://orcid.org/0000-0003-3352-0902View further author information
ORCID Icon,
Andriy Derkachb Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USAView further author information
,
Lohith Gowdaa Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, Yale University, New Haven, CT, USAView further author information
,
Kamal Menghrajanic Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;d Weill Cornell Medical College, New York, NY, USAView further author information
,
Susan DeWolfc Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NYView further author information
,
Josel D. Ruize Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAView further author information
,
Doris M. Ponced Weill Cornell Medical College, New York, NY, USA;e Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAView further author information
,
Brian C. Shafferd Weill Cornell Medical College, New York, NY, USA;e Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAView further author information
,
Roni Tamarid Weill Cornell Medical College, New York, NY, USA;e Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAView further author information
,
James W. Youngd Weill Cornell Medical College, New York, NY, USA;e Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA;f The Rockefeller University, New York, NY, USAView further author information
,
Ann A. Jakubowskid Weill Cornell Medical College, New York, NY, USA;e Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAView further author information
,
Boglarka Gyurkoczad Weill Cornell Medical College, New York, NY, USA;e Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAORCID Iconhttps://orcid.org/0000-0002-2933-2119View further author information
ORCID Icon,
Alexander Chang Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USAView further author information
,
Wenbin Xiaog Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USAView further author information
,
Jacob Glassc Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;d Weill Cornell Medical College, New York, NY, USAView further author information
,
Amber C. Kingh Department of Pharmacy, Memorial Sloan Kettering Cancer Center, New York, NY, USAView further author information
,
Sheng F. Caic Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;d Weill Cornell Medical College, New York, NY, USAView further author information
,
Anthony Daniyanc Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;d Weill Cornell Medical College, New York, NY, USAView further author information
,
Christopher Famularec Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NYView further author information
,
Bernadette M. Cuelloc Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NYView further author information
,
Nikolai A. Podoltseva Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, Yale University, New Haven, CT, USAView further author information
,
Mikhail Roshalg Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USAView further author information
,
Sergio Giraltd Weill Cornell Medical College, New York, NY, USA;e Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAView further author information
,
Miguel-Angel Peralesd Weill Cornell Medical College, New York, NY, USA;e Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAView further author information
,
Stuart Seropiana Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, Yale University, New Haven, CT, USAView further author information
,
Christina Chod Weill Cornell Medical College, New York, NY, USA;e Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USAView further author information
,
Amer M. Zeidana Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, Yale University, New Haven, CT, USAView further author information
,
Thomas Prebeta Section of Hematology, Department of Internal Medicine, Yale University School of Medicine, Yale University, New Haven, CT, USAORCID Iconhttps://orcid.org/0000-0002-6872-625XView further author information
ORCID Icon,
Eytan M. Steinc Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;d Weill Cornell Medical College, New York, NY, USAView further author information
,
Martin S. Tallmanc Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;d Weill Cornell Medical College, New York, NY, USAView further author information
,
Aaron D. Goldbergc Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;d Weill Cornell Medical College, New York, NY, USAView further author information
&
Maximilian Stahlc Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;d Weill Cornell Medical College, New York, NY, USACorrespondence[email protected]
View further author information
 show all
Pages 3394-3401 | Received 09 Jul 2021, Accepted 31 Jul 2021, Published online: 03 Sep 2021

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Jan Philipp Bewersdorf, Rory M. Shallis, Andriy Derkach, Aaron D. Goldberg, Anthony Stein, Eytan M. Stein, Guido Marcucci, Amer M. Zeidan, Shai Shimony, Daniel J. DeAngelo, Richard M. Stone, Ibrahim Aldoss, Brian J. Ball & Maximilian Stahl. (2023) Venetoclax-based salvage therapy in patients with relapsed/refractory acute myeloid leukemia previously treated with FLT3 or IDH1/2 inhibitors. Leukemia & Lymphoma 64:1, pages 188-196.
Read now
Razwana Khanam, Moazzam Shahzad, Sibgha Gull Chaudhary, Fatima Ali, Zunairah Shah, Pranali S. Pachika, Zahoor Ahmed, Asmi Chattaraj, Adeel Masood, Nausheen Ahmed, Rajat Bansal, Ramesh Balusu, Leyla Shune, Faiz Anwar, Peiman Hematti, Joseph P. McGuirk, Abdulraheem Yacoub & Muhammad Umair Mushtaq. (2022) Outcomes after venetoclax with hypomethylating agents in myelodysplastic syndromes: a systematic review and meta-analysis. Leukemia & Lymphoma 63:11, pages 2671-2678.
Read now

Articles from other publishers (8)

Jean El-Cheikh, Ghassan Bidaoui, Mustafa Saleh, Nour Moukalled, Iman Abou Dalle & Ali Bazarbachi. (2023) Venetoclax: A New Partner in the Novel Treatment Era for Acute Myeloid Leukemia and Myelodysplastic Syndrome. Clinical Hematology International 5:2-3, pages 143-154.
Crossref
Cristian Sandoval, Yolanda Calle, Karina Godoy & Jorge Farías. (2023) An Updated Overview of the Role of CYP450 during Xenobiotic Metabolization in Regulating the Acute Myeloid Leukemia Microenvironment. International Journal of Molecular Sciences 24:7, pages 6031.
Crossref
Zhangjie Chen, Sisi Zhen, Tingting Zhang, Yuyan Shen, Aiming Pang, Donglin Yang, Rongli Zhang, Qiaoling Ma, Yi He, Jialin Wei, Weihua Zhai, Xin Chen, Erlie Jiang, Mingzhe Han & Sizhou Feng. (2023) Venetoclax plus hypomethylating agents versus intensive chemotherapy for hematological relapse of myeloid malignancies after allo-HSCT. Frontiers in Oncology 13.
Crossref
Su-Yeon Bang, Silvia Park, Daehun Kwag, Jong Hyuk Lee, Gi-June Min, Sung-Soo Park, Jae-Ho Yoon, Sung-Eun Lee, Byung-Sik Cho, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Jong Wook Lee & Hee-Je Kim. (2023) A Successful Bridge Therapy Combining Hypomethylating Agents with Venetoclax for Adult Patients with Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia. Cancers 15:6, pages 1666.
Crossref
Phaedon D. Zavras, Ilias Sinanidis, Panagiotis Tsakiroglou & Theodoros Karantanos. (2023) Understanding the Continuum between High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia. International Journal of Molecular Sciences 24:5, pages 5018.
Crossref
Maria Klimentova, Larisa Shelikhova, Maria Ilushina, Svetlana Kozlovskaya, Sergei Blagov, Alexander Popov, Svetlana Kashpor, Maria Fadeeva, Julia Olshanskaya, Svetlana Glushkova, Dmitriy Pershin, Dmitriy Balashov, Alexei Maschan & Michael Maschan. (2023) Targeted Therapy With Venetoclax and Daratumumab as Part of HSCT Preparative Regimen in Children With Chemorefractory Acute Myeloid Leukemia. Transplantation and Cellular Therapy 29:2, pages 127.e1-127.e9.
Crossref
Amanda C. Winters, Grace Bosma, Diana Abbott, Mohd Minhajuddin, Craig Jordan, Daniel A. Pollyea & Jonathan A. Gutman. (2022) Outcomes Are Similar After Allogeneic Hematopoietic Stem Cell Transplant for Newly Diagnosed Acute Myeloid Leukemia Patients who Received Venetoclax + Azacitidine Versus Intensive Chemotherapy. Transplantation and Cellular Therapy 28:10, pages 694.e1-694.e9.
Crossref
Jan Philipp Bewersdorf & Omar Abdel-Wahab. (2022) Translating recent advances in the pathogenesis of acute myeloid leukemia to the clinic. Genes & Development 36:5-6, pages 259-277.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.